To investigate the efficacy of Huatan Huoxue decoction on multiple myeloma(MM) of phlegm-stasis obstruction type and its influence on secreted frizzled related protein(SFRP) 3 and glucose regulatory protein(GRP) 78.
The patients with MM admitted to Lianshui county central hospital from January 2022 to December 2024 were selected as the research subjects. They were randomly divided into the observation group(62 cases, treated with chemotherapy+ilarradine+Huatan Huoxue decoction) and the control group(61 cases, treated with chemotherapy+ilarradine) using the simple random method. Both groups were treated continuously for 3 cycles. The main indicator of this study was the clinical total effective rate. The secondary indicators included the levels of SFRP3, GRP78 and inflammatory factors after 1 and 3 cycles of treatment, as well as the visual analogue scale(VAS) for pain, Karnofsky performance status(KPS), and activity of daily living(ADL) scale after 3 cycles of treatment. The safety indicator was the incidence of adverse reactions.
The total effective rate of the observation group was significantly higher than that of the control group(93.55% vs. 80.33%, P<0.05). After 1 and 3 cycles of treatment, the serum levels of SFRP3 and GRP78 in both groups were lower than those before treatment(P<0.05), and the levels in the observation group were lower than those in the control group(P<0.05). The serum levels of interleukin(IL)-6, IL-17 and transforming growth factor-β in both groups were lower than those before treatment(P<0.05), and the levels in the observation group were lower than those in the control group(P<0.05). After 3 cycles of treatment, the VAS scores of both groups were lower than those before treatment(P<0.05), and the score of the observation group was lower than that of the control group(P<0.05). The KPS and ADL scores of both groups were higher than those before treatment(P<0.05), and the scores of the observation group were higher than those of the control group(P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05).
The formula for resolving phlegm and promoting blood circulation can help alleviate symptoms, delay disease progression, improve SFRP3, GRP78 and inflammatory factors levels, withoutt increasing the incidence of adverse reactions in patients with phlegm stasis obstruction type MM.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |